ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

9,402Medicare Part D Prescriptions Filled, Including Refills
$593K Total Retail Price of All Prescriptions
664 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 400 339
SIMVASTATIN 355 312
OMEPRAZOLE 353 270
POTASSIUM CHLORIDE 244 211
AMLODIPINE BESYLATE 237 223
WARFARIN SODIUM 231 192
LOSARTAN POTASSIUM 197 188
PREDNISONE 184 147
CITALOPRAM HBR 153 110
METOPROLOL TARTRATE 147 134
FUROSEMIDE 145 101
LOSARTAN-HYDROCHLOROTHIAZIDE 132 91
TRAMADOL HCL 130 110
METOPROLOL SUCCINATE 127 96
LANTUS 126 96
SERTRALINE HCL 124 108
PRAVASTATIN SODIUM 121 104
METFORMIN HCL 105 76
TAMSULOSIN HCL 101 97
MIRTAZAPINE 101 69
BENAZEPRIL HCL 100 90
CEFUROXIME 99 87
CRESTOR 92 75
HYDROCODONE-ACETAMINOPHEN 89 43 S3
ATORVASTATIN CALCIUM 87 80
PANTOPRAZOLE SODIUM 84 73
AZITHROMYCIN 80 69
ATENOLOL 76 71
TRICOR 75 65
SPIRONOLACTONE 75 60
DONEPEZIL HCL 69 64
BYSTOLIC 67 65
HYDROCHLOROTHIAZIDE 66 61
NOVOLOG 66 39
FLUTICASONE PROPIONATE 65 63
BENAZEPRIL-HYDROCHLOROTHIAZIDE 64 53
POLYETHYLENE GLYCOL 3350 63 50
DIOVAN 63 46
LANTUS SOLOSTAR 62 52
LISINOPRIL 61 47
CIPROFLOXACIN HCL 61 50
DIGOXIN 61 57
ZOLPIDEM TARTRATE 60 51
GABAPENTIN 58 38
TRIAMTERENE-HCTZ 57 51
ALLOPURINOL 55 52
CEPHALEXIN 54 44
NEXIUM 54 45
ENALAPRIL MALEATE 54 46
GLIMEPIRIDE 53 52
ZETIA 52 45
ALENDRONATE SODIUM 52 52
RAMIPRIL 51 51
METHYLPHENIDATE HCL 51 36
VENLAFAXINE HCL ER 50 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.